A new study reveals that family caregivers of Alzheimer’s patients in Oman face significant unmet needs, ranging from limited knowledge about the disease to high psychological stress and… read more.
Families are feeling stressed, powerless and ‘forever in limbo’ as they wait months, or sometimes years, for Attention-Deficit Hyperactivity Disorder (ADHD) assessments, according to a new study. Research led by the University of Southampton and King’s College London examined… read more.
A landmark Lancet Psychiatry paper published today – the largest-ever review of the safety and efficacy of cannabinoids across a range of mental health conditions – found no evidence that medicinal cannabis is… read more.
GLP-1 medications, which are used to treat diabetes and obesity, appear to be associated with reduced hospital care and sickness absence from work for psychiatric reasons, researchers reported… read more.
Experts are warning that far from being over diagnosed, people with ADHD are waiting too long for assessment, support and treatment. In a paper, published today in the British… read more.
Canadian researchers report that new stimulant prescriptions to treat ADHD among adults have more than doubled since the start of the COVID-19 pandemic. And this finding was especially… read more.
The EMA has recommended the refusal of the marketing authorisation for Iloperidone Vanda Pharmaceuticals, a medicine intended for the treatment of schizophrenia and manic or mixed episodes associated… read more.
A large registry study in Finland by the University of Oulu and the University of Eastern Finland shows that many older adults receive antipsychotic medications for purposes other… read more.
BioXcel Therapeutics Inc. announced the completion of an updated market opportunity assessment for Igalmi (dexmedetomidine) for acute agitation associated with bipolar disorders or schizophrenia in the at-home (outpatient)… read more.
Older adults who experience delirium after hip fracture surgery face a significantly faster decline in memory and thinking skills than those who don’t, according to a new study…. read more.
Nxera Pharma Co., Ltd. announces that positive top-line results were obtained from a Phase III study conducted in South Korea evaluating daridorexant 50 mg in adult and elderly… read more.
When agitated dementia patients wander or shout through the night, families and caregivers understandably feel the need to treat this frightening and potentially dangerous behavior. Antipsychotic medications are… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
